These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35069447)

  • 1. Decrease in Salivary Serotonin in Response to Probiotic Supplementation With
    Karbownik MS; Kręczyńska J; Wiktorowska-Owczarek A; Kwarta P; Cybula M; Stilinović N; Pietras T; Kowalczyk E
    Front Endocrinol (Lausanne); 2021; 12():800023. PubMed ID: 35069447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Supplementation with
    Karbownik MS; Kręczyńska J; Kwarta P; Cybula M; Wiktorowska-Owczarek A; Kowalczyk E; Pietras T; Szemraj J
    Nutrients; 2020 May; 12(5):. PubMed ID: 32438624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial.
    Villar-García J; Güerri-Fernández R; Moya A; González A; Hernández JJ; Lerma E; Guelar A; Sorli L; Horcajada JP; Artacho A; D Auria G; Knobel H
    PLoS One; 2017; 12(4):e0173802. PubMed ID: 28388647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Saccharomyces boulardii in Infants and Children With Acute Diarrhea.
    Mourey F; Sureja V; Kheni D; Shah P; Parikh D; Upadhyay U; Satia M; Shah D; Troise C; Decherf A
    Pediatr Infect Dis J; 2020 Nov; 39(11):e347-e351. PubMed ID: 32796401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Saccharomyces Boulardii CNCM I-745 probiotic in acute inflammatory viral diarrhoea in adults: results from a single-centre randomized trial.
    Salazar-Parra MA; Cruz-Neri RU; Trujillo-Trujillo XA; Dominguez-Mora JJ; Cruz-Neri HI; Guzmán-Díaz JM; Guzmán-Ruvalcaba MJ; Vega-Gastelum JO; Ascencio-Díaz KV; Zarate-Casas MF; González-Ponce FY; Barbosa-Camacho FJ; Fuentes-Orozco C; Cervantes-Guevara G; Cervantes-Pérez E; Cervantes-Cardona GA; Cortés-Flores AO; González-Ojeda A
    BMC Gastroenterol; 2023 Jul; 23(1):229. PubMed ID: 37400812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of
    Maev IV; Andreev DN; Sokolov PS; Fomenko AК; Devkota MK; Andreev NG; Zaborovsky AV
    Ter Arkh; 2022 Nov; 94(10):1163-1170. PubMed ID: 36468990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of probiotic Saccharomyces boulardii on the mental health, quality of life, fatigue, pain, and indices of inflammation and oxidative stress in patients with multiple sclerosis: study protocol for a double-blind randomized controlled clinical trial.
    Aghamohammadi D; Ayromlou H; Dolatkhah N; Jahanjoo F; Shakouri SK
    Trials; 2019 Jun; 20(1):379. PubMed ID: 31234904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial.
    Pozzoni P; Riva A; Bellatorre AG; Amigoni M; Redaelli E; Ronchetti A; Stefani M; Tironi R; Molteni EE; Conte D; Casazza G; Colli A
    Am J Gastroenterol; 2012 Jun; 107(6):922-31. PubMed ID: 22472744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 60-Day
    Rondanelli M; Miraglia N; Putignano P; Castagliuolo I; Brun P; Dall'Acqua S; Peroni G; Faliva MA; Naso M; Nichetti M; Infantino V; Perna S
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity of
    Czerucka D; Rampal P
    World J Gastroenterol; 2019 May; 25(18):2188-2203. PubMed ID: 31143070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective randomized controlled study on the effects of Saccharomyces boulardii CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers.
    Kabbani TA; Pallav K; Dowd SE; Villafuerte-Galvez J; Vanga RR; Castillo NE; Hansen J; Dennis M; Leffler DA; Kelly CP
    Gut Microbes; 2017 Jan; 8(1):17-32. PubMed ID: 27973989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blinded randomized trial on growth and feeding tolerance with Saccharomyces boulardii CNCM I-745 in formula-fed preterm infants.
    Xu L; Wang Y; Wang Y; Fu J; Sun M; Mao Z; Vandenplas Y
    J Pediatr (Rio J); 2016; 92(3):296-301. PubMed ID: 26946967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases.
    Kaźmierczak-Siedlecka K; Ruszkowski J; Fic M; Folwarski M; Makarewicz W
    Curr Microbiol; 2020 Sep; 77(9):1987-1996. PubMed ID: 32472262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: yeast as probiotics -- Saccharomyces boulardii.
    Czerucka D; Piche T; Rampal P
    Aliment Pharmacol Ther; 2007 Sep; 26(6):767-78. PubMed ID: 17767461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Acute Multispecies and Multistrain Probiotic Supplementation on Cardiovascular Function and Reactivity to Psychological Stress in Young Adults: A Double-Blind, Randomized, Placebo-Controlled Trial.
    Möller CM; Olsa EJA; Ginty AT; Rapelje AL; Tindall CL; Holesh LA; Petersen KL; Conklin SM
    Psychosom Med; 2017 Oct; 79(8):914-919. PubMed ID: 28498275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, direct comparison study of Saccharomyces boulardii CNCM I-745 versus multi-strained Bacillus clausii probiotics for the treatment of pediatric acute gastroenteritis.
    Altcheh J; Carosella MV; Ceballos A; D'Andrea U; Jofre SM; Marotta C; Mugeri D; Sabbaj L; Soto A; Josse C; Montestruc F; McFarland LV
    Medicine (Baltimore); 2022 Sep; 101(36):e30500. PubMed ID: 36086703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of
    Ghosh A; Sundaram B; Bhattacharya P; Mohanty N; Dheivamani N; Mane S; Acharyya B; Kamale V; Poddar S; Khobragade A; Thomas W; Prabhudesai S; Choudhary A; Mitra M
    Pediatr Gastroenterol Hepatol Nutr; 2021 Sep; 24(5):423-431. PubMed ID: 34557395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Efficacy Comparison of Saccharomyces Boulardii and Lactic Acid as Probiotics in Acute Pediatric Diarrhea.
    Asmat S; Shaukat F; Asmat R; Bakhat HFSG; Asmat TM
    J Coll Physicians Surg Pak; 2018 Mar; 28(3):214-217. PubMed ID: 29544579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of probiotics (Saccharomyces boulardii) on microbial translocation and inflammation in HIV-treated patients: a double-blind, randomized, placebo-controlled trial.
    Villar-García J; Hernández JJ; Güerri-Fernández R; González A; Lerma E; Guelar A; Saenz D; Sorlí L; Montero M; Horcajada JP; Knobel Freud H
    J Acquir Immune Defic Syndr; 2015 Mar; 68(3):256-63. PubMed ID: 25469528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saccharomyces boulardii CNCM I-745 probiotic does not alter the pharmacokinetics of amoxicillin.
    Selig DJ; DeLuca JP; Li Q; Lin H; Nguyen K; Scott SM; Sousa JC; Vuong CT; Xie LH; Livezey JR
    Drug Metab Pers Ther; 2020 Mar; 35(1):. PubMed ID: 32134728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.